Skip to main content
Diabetes MellitusSleepSupplementsNutrition and dietDrugPhase 2

What this study is

This study explores the use of melatonin in patients with diabetic retinopathy

What's being tested

  • Melatonin

    Intervention · DRUG

    Melatonin 3 mg will be taken nightly for 8 weeks

  • Placebo

    Intervention · OTHER

    Placebo will be given nightly for 8 weeks

Study details

Official title
Sleep and Circadian Regulation in Diabetic Retinopathy: The Role of Intrinsically Photosensitive Retinal Ganglion Cells and Melatonin Supplementation
Sponsor
University of Illinois at Chicago
Conditions
Diabetes Mellitus · Diabetic Retinopathy
Enrolling
42 people
Starts
2021-02-03
Est. completion
2026-06
Design
Triple-blind, randomized, parallel groups, Phase 2
Record
View on ClinicalTrials.gov ↗